F+FreeMedSite USMLELearn with clinical reasoning
USMLE Step 1High-yield → advanced clinical decision-making

Question 028 / 40 published

USMLE-STYLE CLINICAL SCENARIOGLP-1 receptor agonists: incretin signaling
A 51-year-old man with obesity and type 2 diabetes begins a GLP-1 receptor agonist. Over the next several months his HbA1c and body weight decrease. Which combination most accurately describes the glucose-lowering physiology of this treatment?
Select one best answer
Next question →
← Previous